CLINICAL_TRIALS
research
· 2026-04-16
Clinical Trial Update: A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma [Phase 2]
Summary
A Phase 2 clinical trial evaluating JZP3507 (ONC206) in recurrent Grade 2 or 3 meningioma, with recruitment not yet started.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jazz Pharmaceuticals | Conditions: Meningioma | Phase 2 | Status: NOT_YET_RECRUITING